Schwerpunkte der Nachsorge und Langzeiterfolg nach der Katheterablation des Vorhofflimmerns

Übersicht

Abstract

During the last twenty years catheter ablation of atrial fibrillation has evolved from an experimental method to a standard rhythm control strategy for patients suffering from drug refractory atrial fibrillation. Continuous enhancements and simplification of technologies lead to ready availability of this treatment option. Despite promising short and mid-term results data on long term efficacy are lacking. Beside documentation of arrhythmia recurrences an adequate follow up serves as key position for relevant clinical decisions. In the first weeks after the ablation procedure, follow up focused on detection of sub-acute procedural complications. During the next months statements on rhythm outcome are possible, additionally, adaptation of medical therapy, e. g. regarding antiarrhythmic or anticoagulation are made. Finally long term follow up provides additional information on rhythm outcome and durable success of the ablation procedure.

• Literatur

• 1 Kim JS, Jongnarangsin K, Latchamsetty R et al. The Optimal Range of International Normalized Ratio for Radiofrequency Catheter Ablation of Atrial Fibrillation during Therapeutic Anticoagulation with Warfarin. Circ Arrhythm Electrophysiol 2013; Feb 26;
• 2 Cappato R, Calkins H, Chen SA et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol 2011; 58: 2696-2697
• 3 Shah D, Dumonceau JM, Burri H et al. Acute pyloric spasm and gastric hypomotility: an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol 2005; 46: 327-330
• 4 Bauer A, Deisenhofer I, Schneider R et al. Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm 2006; 3: 1428-1435
• 5 Halm U, Gaspar T, Zachäus M et al. Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias. Am J Gastroenterol 2010; 105: 551-556
• 6 Singh SM, d'Avila A, Doshi SK et al. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol 2008; 1: 162-168
• 7 Gilcrease GW, Stein JB. A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 708-711
• 8 Dagres N, Anastasiou-Nana M. Prevention of atrial-esophageal fistula after catheter ablation of atrial fibrillation. Curr Opin Cardiol 2011; 26: 1-5
• 9 Leong-Sit P, Roux JF, Zado E et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol 2011; 4: 11-14
• 10 Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606
• 11 Dong J, Vasamreddy CR, Jayam V et al. Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging. J Cardiovasc Electrophysiol 2005; 16: 845-852
• 12 Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105
• 13 Packer D, Irwin J, Champagne J. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front STOP-AF pivotal trial. J Am Coll Cardiol 2010; 56: E3015-3016
• 14 Thomas D, Katus HA, Voss F. Asymptomatic pulmonary vein stenosis after cryoballoon catheter ablation of paroxysmal atrial fibrillation. J Electrocardiol 2011; 44: 473-476
• 15 Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313
• 16 Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16: 1286-1292
• 17 Chao TF, Lin YJ, Tsao HM et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011; 58: 2380-2385
• 18 Kobza R, Hindricks G, Tanner H et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm 2004; 1: 676-683
• 19 Verma A, Kilicaslan F, Pisano E et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation 2005; 112: 627-635
• 20 Weerasooriya R, Khairy P, Litalien J et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?. J Am Coll Cardiol 2011; 57: 160-166
• 21 Pappone C, Vicedomini G, Augello G et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol 2011; 4: 808-814
• 22 Tzou WS, Marchlinski FE, Zado ES et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 237-242
• 23 Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38